Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue sarcoma, ovarian carcinoma, and endometrial carcinoma

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter: 12 X users

Readers on

mendeley: 21 Mendeley

Summary X

So far, Altmetric has seen 24 X posts from 12 X users, with an upper bound of 39,160 followers.

RT @DrImranSheikh: Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue…

27 Nov 2022

Reply Repost Favourite

RT @DrImranSheikh: Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue…

26 Nov 2022

Reply Repost Favourite

RT @DrImranSheikh: Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue…

26 Nov 2022

Reply Repost Favourite

Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue sarcoma, ovarian carcinoma, and endometrial carcinoma https://t.co/wpPCwR3n1e https://t.co/QS25Vxk6U4

26 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 20 additional X posts.